Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation

J Clin Oncol. 2025 Jan 13:JCO2402305. doi: 10.1200/JCO-24-02305. Online ahead of print.

Authors

Jing Tan¹, Lin Chen¹, Rui Zhu¹

Affiliation

¹ Jing Tan, MD, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China; Lin Chen, MM, School of Medicine, North Scihuan Medical College, Nanchong, Sichuan, China; and Rui Zhu, MM, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.

PMID: 39805074
DOI: 10.1200/JCO-24-02305

No abstract available

Publication types

Letter